Board of Directors

Gary Wilcox, Ph.D.

Chairman of the Board and Chief Executive Officer

Gary Wilcox has over 35 years of experience in biotech companies including 14 years at Icos Corporation (NASDAQ: ICOS) where he played a key role in the development of Cialis as the Executive Vice President of Operations and a member of the board of directors. Prior to that, he served as Vice Chairman, Executive Vice President and a Director of Xoma Corporation (NASDAQ: XOMA). Prior to Xoma, Dr. Wilcox co-founded Ingene Inc. (NASDAQ: IGEI) serving as its Chairman, President and CEO prior to the merger of Ingene into Xoma. Dr. Wilcox was a Professor of Microbiology and a member of the Molecular Biology Institute at UCLA for 10 years. He has served on 15 boards of directors including NASDAQ, New York and London stock exchange companies, as well as private technology companies.

Roger Kornberg, Ph.D.

Director, Chief Scientist and Chairman of Scientific Advisory Board

Dr. Kornberg is a member of the U.S. National Academy of Sciences and the Winzer Professor of Medicine in the Department of Structural Biology at Stanford University. He has been a member of the faculty of Stanford University since 1978. In 2006, Dr. Kornberg was awarded the Nobel Prize in Chemistry in recognition for his studies of the molecular basis of Eukaryotic Transcription, the process by which DNA is copied to RNA. Dr. Kornberg is also the recipient of several awards, including the 2001 Welch Prize, the highest award granted in the field of chemistry in the United States, and the 2002 Leopald Mayer Prize, the highest award granted in the field of biomedical sciences from the French Academy of Sciences.

Committees

Committee Role
Nominating and Corporate Governance Committee Chair
Scientific Review Committee Chair
Compensation Committee Member

Phillip Frost, M.D.

Director

Phillip Frost, M.D., is the Chairman and CEO of OPKO Health, Inc. (NYSE: OPK). Dr. Frost is the former Chairman of the Board of Teva Pharmaceuticals (NYSE: TEVA). In January 2006 Teva acquired IVAX Corporation. Dr. Frost had served as Chairman and CEO of IVAX Corporation since 1987. He has served on the Board of Regents of the Smithsonian Institution, on the Board of Trustees of the University of Miami, as a Trustee of each of the Scripps Research Institutes, and is a director of numerous other organizations.

Committees

Committee Role
Audit Committee Member

Anthony Japour, M.D.

Director

Anthony Japour, M.D. currently serves on the Boston Advisory Council for the George Washington School of Business Transformative Leadership during Disruptive Times Certificate Program. He recently served as CEO of AdvancedDx Biological Laboratories-USA (ABLDx-USA), a virologic diagnostic solutions company from May 2020 to August 2020 and as Medical Director of ICON plc, a global provider of outsourced drug development and commercialization solutions and services to the pharmaceutical, biotechnology, medical device and government and public health organizations from February 2016 to April 2020. Prior to that, from April 2012 to February 2016, Dr. Japour worked as an internal medicine physician at Elite Health Medical Group in Miami Beach, Florida, where he specialized in infectious diseases. Dr. Japour is also the owner and director of Anthony Japour and Associates, Medical and Scientific Consulting, Inc., a medical and scientific consulting firm he established in November 2006.

Committees

Committee Role
Audit Committee Member
Compensation Committee Member
Nominating and Corporate Governance Committee Member

Steve Rubin

Director

Steve Rubin is Executive Vice President-Administration and a director of OPKO Health, Inc. Previously, he was Senior Vice President and General Counsel of IVAX. Prior to IVAX, Mr. Rubin was Senior Vice President and General Counsel of Telergy Inc. Mr. Rubin holds a B.A. from Tulane University and a J.D. degree from University of Florida.

Committees

Committee Role
Audit Committee Chair
Compensation Committee Chair
Nominating and Corporate Governance Committee Member